{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:09:47Z","timestamp":1757621387456,"version":"3.44.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Mucopolysaccharidosis IIIB (MPS IIIB) is a metabolic neurodegenerative disorder caused by a deficiency of the lysosomal enzyme \u03b1-N-acetylglucosaminidase (NAGLU), which is involved in the degradation of heparan sulfate (HS). Affected patients exhibit progressive neurodegeneration, behavioral disturbances, and a shortened lifespan. Currently, there is no effective treatment for MPS IIIB. We have recently developed a new therapeutic strategy based on the use of the HS-binding protein NK1, a spliced variant of hepatocyte growth factor. Here, we demonstrate that treating <jats:italic>Naglu<\/jats:italic>\n            <jats:sup>\u2212\/\u2212<\/jats:sup> mice with recombinant NK1 ameliorates neuropathology by reducing HS storage, lysosomal dysfunction, autophagy imbalance, and neuroinflammation in the cortex and hippocampus of MPS IIIB mouse brains. Furthermore, we found that recombinant NK1 treatment improves cognitive behavior and motor activity in <jats:italic>Naglu<\/jats:italic>\n            <jats:sup>\u2212\/\u2212<\/jats:sup> mice, as assessed using open field, object recognition, and T-maze tests. Our findings suggest that recombinant NK1 is a promising candidate for the treatment of MPS IIIB and other lysosomal storage diseases associated with central nervous system dysfunction.<\/jats:p>","DOI":"10.1038\/s41420-025-02648-w","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T19:42:07Z","timestamp":1754077327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heparan sulfate binding protein treatment ameliorates neuropathology and behavioral abnormalities in mucopolysaccharidosis IIIB mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Serenella","family":"Anzilotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Scarcella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Ciampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noemi","family":"Di Muraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Rossin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Avallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Michele","family":"Pavone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-1980","authenticated-orcid":false,"given":"Valeria","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2648_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","volume":"4","author":"FM Platt","year":"2018","unstructured":"Platt FM, d\u2019Azzo A, Davidson BL, Neufeld EF, Tifft CJ. Lysosomal storage diseases. Nat. Rev. Dis. Prim. 2018;4:27.","journal-title":"Nat. Rev. Dis. Prim"},{"key":"2648_CR2","doi-asserted-by":"publisher","first-page":"220155","DOI":"10.1098\/rsob.220155","volume":"12","author":"G Scerra","year":"2022","unstructured":"Scerra G, De Pasquale V, Scarcella M, Caporaso MG, Pavone LM, D\u2019Agostino M. Lysosomal positioning diseases: beyond substrate storage. Open Biol. 2022;12:220155.","journal-title":"Open Biol."},{"key":"2648_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-022-02484-6","volume":"17","author":"N Muschol","year":"2022","unstructured":"Muschol N, Giugliani R, Jones SA, Muenzer J, Smith NJC, Whitley CB, et al. Sanfilippo syndrome:consensus guidelines for clinical care. Orphanet J. Rare Dis. 2022;17:391.","journal-title":"Orphanet J. Rare Dis."},{"key":"2648_CR4","doi-asserted-by":"crossref","unstructured":"The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001. J Inherit Metab Dis 2001;24:519-20.","DOI":"10.1023\/A:1017409002434"},{"key":"2648_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","volume":"31","author":"MJ Valstar","year":"2008","unstructured":"Valstar MJ, Ruijter GJG, van Diggelen OP, Poorthuis BJ, Wijburg FA. Sanfilippo syndrome:a mini-review. J. Inherit. Metab. Dis. 2008;31:240\u201352.","journal-title":"J. Inherit. Metab. Dis."},{"key":"2648_CR6","doi-asserted-by":"publisher","first-page":"165539","DOI":"10.1016\/j.bbadis.2019.165539","volume":"1865","author":"V De Pasquale","year":"2019","unstructured":"De Pasquale V, Pavone LM. Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses. Biochim Biophys. Acta Mol. Basis Dis. 2019;1865:165539.","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"2648_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/jcm9020396","volume":"9","author":"GM Viana","year":"2020","unstructured":"Viana GM, Priestman DA, Platt FM, Khan S, Tomatsu S, Pshezhetsky AV. Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms. J. Clin. Med. 2020;9:396.","journal-title":"J. Clin. Med"},{"key":"2648_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","volume":"36","author":"EM Cross","year":"2013","unstructured":"Cross EM, Hare DJ. Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. J. Inherit. Metab. Dis. 2013;36:189\u2013200.","journal-title":"J. Inherit. Metab. Dis."},{"key":"2648_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1150-1","volume":"14","author":"E Shapiro","year":"2019","unstructured":"Shapiro E, Louren\u00e7o CM, Mungan NO, Muschol N, O\u2019Neill C, Vijayaraghavan S. Analysis ofthe caregiver burden associated with Sanfilippo syndrome type B: panel recommendations based on qualitative and quantitative data. Orphanet J. Rare Dis. 2019;14:168.","journal-title":"Orphanet J. Rare Dis."},{"key":"2648_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/jcm9020344","volume":"9","author":"R Heon-Roberts","year":"2020","unstructured":"Heon-Roberts R, Nguyen ALA, Pshezhetsky AV. Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease. J. Clin. Med. 2020;9:344.","journal-title":"J. Clin. Med"},{"key":"2648_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42431-4","volume":"13","author":"R Petrova","year":"2023","unstructured":"Petrova R, Patil AR, Trinh V, McElroy KE, Bhakta M, Tien J, et al. Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB. Sci. Rep. 2023;13:16699.","journal-title":"Sci. Rep"},{"key":"2648_CR12","doi-asserted-by":"publisher","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","volume":"7","author":"FL Wilkinson","year":"2012","unstructured":"Wilkinson FL, Holley RJ, Langford-Smith KJ, Badrinath S, Liao A, Langford-Smith A, et al. Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB. PLoS One. 2012;7:e35787.","journal-title":"PLoS One"},{"key":"2648_CR13","doi-asserted-by":"publisher","first-page":"E979","DOI":"10.3390\/cells9040979","volume":"9","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale V, Moles A, Pavone LM. Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy. Cells. 2020;9:E979.","journal-title":"Cells"},{"key":"2648_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/biom10030355","volume":"10","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale V, Costanzo M, Siciliano RA, Mazzeo MF, Pistorio V, Bianchi L, et al. Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain. Biomolecules. 2020;10:355.","journal-title":"Biomolecules"},{"key":"2648_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ymgme.2020.07.006","volume":"131","author":"A Derrick-Roberts","year":"2020","unstructured":"Derrick-Roberts A, Kaidonis X, Jackson MR, Liaw WC, Ding X, Ong C, et al. Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses. Mol. Genet Metab. 2020;131:197\u2013205.","journal-title":"Mol. Genet Metab."},{"key":"2648_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.omtm.2018.05.002","volume":"10","author":"V De Pasquale","year":"2018","unstructured":"De Pasquale V, Sarogni P, Pistorio V, Cerulo G, Paladino S, Pavone LM. Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses. Mol. Ther. Methods Clin. Dev. 2018;10:8\u201316.","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"2648_CR17","doi-asserted-by":"publisher","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","volume":"96","author":"HH Li","year":"1999","unstructured":"Li HH, Yu WH, Rozengurt N, Zhao HZ, Lyons KM, Anagnostaras S, et al. Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc. Natl Acad. Sci. USA. 1999;96:14505\u201310.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2648_CR18","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1371\/journal.pone.0000772","volume":"2","author":"CD Heldermon","year":"2007","unstructured":"Heldermon CD, Hennig AK, Ohlemiller KK, Ogilvie JM, Herzog ED, Breidenbach A, et al. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS One. 2007;2:e772.","journal-title":"PLoS One"},{"key":"2648_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbr.2016.06.023","volume":"312","author":"Shsin Kan","year":"2016","unstructured":"Kan Shsin, Le SQ, Bui QD, Benedict B, Cushman J, Sands MS, et al. Behavioral deficits and cholinergic pathway abnormalities in male Sanfilippo B mice. Behavioural Brain Res. 2016;312:265\u201371.","journal-title":"Behavioural Brain Res."},{"key":"2648_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymgme.2017.10.007","volume":"122","author":"M Scarpa","year":"2017","unstructured":"Scarpa M, Orchard PJ, Schulz A, Dickson PI, Haskins ME, Escolar ML, et al. Treatment of brain disease in the mucopolysaccharidoses. Mol. Genet. Metab. 2017;122:25\u201334.","journal-title":"Mol. Genet. Metab."},{"key":"2648_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jimd.12316","volume":"44","author":"B Seker Yilmaz","year":"2021","unstructured":"Seker Yilmaz B, Davison J, Jones SA, Baruteau J. Novel therapies for mucopolysaccharidosis type III. J. Inherit. Metab. Dis. 2021;44:129\u201347.","journal-title":"J. Inherit. Metab. Dis."},{"key":"2648_CR22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00109-020-01935-6","volume":"98","author":"AF Leal","year":"2020","unstructured":"Leal AF, Espejo-Mojica AJ, S\u00e1nchez OF, Ram\u00edrez CM, Reyes LH, Cruz JC, et al. Lysosomal storage diseases:current therapies and future alternatives. J. Mol. Med (Berl). 2020;98:931\u201346.","journal-title":"J. Mol. Med (Berl)"},{"key":"2648_CR23","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1074\/jbc.271.22.13110","volume":"271","author":"V Cioce","year":"1996","unstructured":"Cioce V, Csaky KG, Chan AM, Bottaro DP, Taylor WG, Jensen R, et al. Hepatocyte growth factor(HGF)\/NK1 is a naturally occurring HGF\/scatter factor variant with partial agonist\/antagonistactivity. J. Biol. Chem. 1996;271:13110\u20135.","journal-title":"J. Biol. Chem."},{"key":"2648_CR24","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.1074\/jbc.M807671200","volume":"284","author":"JA Deakin","year":"2009","unstructured":"Deakin JA, Blaum BS, Gallagher JT, Uhr\u00edn D, Lyon M. The binding properties of minimal oligosaccharides reveal a common heparan sulfate\/dermatan sulfate-binding site in hepatocyte growth factor\/scatter factor that can accommodate a wide variety of sulfation patterns. J. Biol. Chem. 2009;284:6311\u201321.","journal-title":"J. Biol. Chem."},{"key":"2648_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40120-020-00226-z","volume":"10","author":"KA Porter","year":"2021","unstructured":"Porter KA, O\u2019Neill C, Drake E, Parker S, Escolar ML, Montgomery S, et al. Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment. Neurol. Ther. 2021;10:197\u2013212.","journal-title":"Neurol. Ther."},{"key":"2648_CR26","doi-asserted-by":"publisher","first-page":"119113","DOI":"10.1016\/j.bbamcr.2021.119113","volume":"1868","author":"V De Pasquale","year":"2021","unstructured":"De Pasquale V, Scerra G, Scarcella M, D\u2019Agostino M, Pavone LM. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB. Biochim Biophys. Acta Mol. Cell Res. 2021;1868:119113.","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"key":"2648_CR27","doi-asserted-by":"publisher","first-page":"108959","DOI":"10.1016\/j.isci.2024.108959","volume":"27","author":"M Scarcella","year":"2024","unstructured":"Scarcella M, Scerra G, Ciampa M, Caterino M, Costanzo M, Rinaldi L, et al. Metabolic rewiring and autophagy inhibition correct lysosomal storage disease in mucopolysaccharidosis IIIB. iScience. 2024;27:108959.","journal-title":"iScience"},{"key":"2648_CR28","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1097\/PAI.0000000000000925","volume":"29","author":"L Luijerink","year":"2021","unstructured":"Luijerink L, Waters KA, Machaalani R. Immunostaining for NeuN Does Not Show all Mature and Healthy Neurons in the Human and Pig Brain: Focus on the Hippocampus. Appl Immunohistochem. Mol. Morphol. 2021;29:e46\u2013e56.","journal-title":"Appl Immunohistochem. Mol. Morphol."},{"key":"2648_CR29","doi-asserted-by":"publisher","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","volume":"5","author":"M Malinowska","year":"2010","unstructured":"Malinowska M, Wilkinson FL, Langford-Smith KJ, Langford-Smith A, Brown JR, Crawford BE, et al. Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease. PLOS ONE. 2010;5:e14192.","journal-title":"PLOS ONE"},{"key":"2648_CR30","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ymgme.2018.08.003","volume":"125","author":"BW Bigger","year":"2018","unstructured":"Bigger BW, Begley DJ, Virgintino D, Pshezhetsky AV. Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders. Mol. Genet Metab. 2018;125:322\u201331.","journal-title":"Mol. Genet Metab."},{"key":"2648_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/cells6030020","volume":"6","author":"I Orhon","year":"2017","unstructured":"Orhon I, Reggiori F. Assays to Monitor Autophagy Progression in Cell Cultures. Cells. 2017;6:20.","journal-title":"Cells"},{"key":"2648_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/7651_2018_124","volume":"1854","author":"W Li","year":"2019","unstructured":"Li W, Li S, Li Y, Lin X, Hu Y, Meng T, Wu B, He R, Feng D. Immunofluorescence Staining Protocols for Major Autophagy Proteins Including LC3, P62, and ULK1 in Mammalian Cells in Response to Normoxia and Hypoxia. Methods Mol. Biol. 2019;1854:175\u201385.","journal-title":"Methods Mol. Biol."},{"key":"2648_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11011-010-9230-x","volume":"26","author":"DM McCarty","year":"2011","unstructured":"McCarty DM, DiRosario J, Gulaid K, Killedar S, Oosterhof A, van Kuppevelt TH, et al. Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice. Metab. Brain Dis. 2011;26:9\u201319.","journal-title":"Metab. Brain Dis."},{"key":"2648_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-020-0141-7","volume":"6","author":"WW-Y Yim","year":"2020","unstructured":"Yim WW-Y, Mizushima N. Lysosome biology in autophagy. Cell Discov. 2020;6:6.","journal-title":"Cell Discov."},{"key":"2648_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1042\/EBC20170055","volume":"61","author":"E Seranova","year":"2017","unstructured":"Seranova E, Connolly KJ, Zatyka M, Rosenstock TR, Barrett T, Tuxworth RI, et al. Dysregulation of autophagy as a common mechanism in lysosomal storage diseases. Essays Biochem. 2017;61:733\u201349.","journal-title":"Essays Biochem"},{"key":"2648_CR36","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/15548627.2015.1046671","volume":"12","author":"AV Pshezhetsky","year":"2016","unstructured":"Pshezhetsky AV. Lysosomal storage of heparan sulfate causes mitochondrial defects, altered autophagy, and neuronal death in the mouse model of mucopolysaccharidosis III type C. Autophagy. 2016;12:1059\u201360.","journal-title":"Autophagy"},{"key":"2648_CR37","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1515\/jpem-2020-0742","volume":"34","author":"W Kong","year":"2021","unstructured":"Kong W, Wu S, Zhang J, Lu C, Ding Y, Meng Y. Global epidemiology of mucopolysaccharidosis type III (Sanfilippo syndrome): an updated systematic review and meta-analysis. J. Pediatr. Endocrinol. Metab. 2021;34:1225\u201335.","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"2648_CR38","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.3390\/ijms21217819","volume":"21","author":"N Benet\u00f3","year":"2020","unstructured":"Benet\u00f3 N, Vilageliu L, Grinberg D, Canals I. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches. Int J. Mol. Sci. 2020;21:7819.","journal-title":"Int J. Mol. Sci."},{"key":"2648_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/1673-5374.377606","volume":"19","author":"CJ Rouse","year":"2024","unstructured":"Rouse CJ, Jensen VN, Heldermon CD. Mucopolysaccharidosis type IIIB: a current review and exploration of the AAV therapy landscape. Neural Regen. Res. 2024;19:355\u20139.","journal-title":"Neural Regen. Res"},{"key":"2648_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41577-022-00698-0","volume":"22","author":"CT Charlesworth","year":"2022","unstructured":"Charlesworth CT, Hsu I, Wilkinson AC, Nakauchi H. Immunological barriers to haematopoietic stem cell gene therapy. Nat. Rev. Immunol. 2022;22:719\u201333.","journal-title":"Nat. Rev. Immunol."},{"key":"2648_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40259-023-00585-7","volume":"37","author":"M Arjomandnejad","year":"2023","unstructured":"Arjomandnejad M, Dasgupta I, Flotte TR, Keeler AM. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer. BioDrugs. 2023;37:311\u201329.","journal-title":"BioDrugs"},{"key":"2648_CR42","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1021\/acs.jmedchem.2c01617","volume":"66","author":"V De Pasquale","year":"2023","unstructured":"De Pasquale V, Esposito A, Scerra G, Scarcella M, Ciampa M, Luongo A, et al. N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndrome. J. Med Chem. 2023;66:1790\u2013808.","journal-title":"J. Med Chem"},{"key":"2648_CR43","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.3390\/ijms21124211","volume":"21","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale V, Caterino M, Costanzo M, Fedele R, Ruoppolo M, Pavone LM. Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism. Int J. Mol. Sci. 2020;21:4211.","journal-title":"Int J. Mol. Sci."},{"key":"2648_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/brain\/awx311","volume":"141","author":"RJ Holley","year":"2018","unstructured":"Holley RJ, Ellison SM, Fil D, O\u2019Leary C, McDermott J, Senthivel N, et al. Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy. Brain. 2018;141:99\u2013116.","journal-title":"Brain"},{"key":"2648_CR45","doi-asserted-by":"publisher","first-page":"102707","DOI":"10.1016\/j.isci.2021.102707","volume":"24","author":"G Scerra","year":"2021","unstructured":"Scerra G, De Pasquale V, Pavone LM, Caporaso MG, Mayer A, Renna M, et al. Early onset effects of single substrate accumulation recapitulate major features of LSD in patient-derived lysosomes. iScience. 2021;24:102707.","journal-title":"iScience"},{"key":"2648_CR46","doi-asserted-by":"publisher","first-page":"e0131662","DOI":"10.1371\/journal.pone.0131662","volume":"10","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella GG, Cerulo G, Pasquale VD, Cocchiaro P, Paciello O, Avallone L, et al. The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure. PLOS ONE. 2015;10:e0131662.","journal-title":"PLOS ONE"},{"key":"2648_CR47","doi-asserted-by":"publisher","first-page":"e0233050","DOI":"10.1371\/journal.pone.0233050","volume":"15","author":"MP Belfiore","year":"2020","unstructured":"Belfiore MP, Iacobellis F, Acampora E, Caiazza M, Rubino M, Monda E, et al. Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases. PLoS One. 2020;15:e0233050.","journal-title":"PLoS One"},{"key":"2648_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0187-0","volume":"9","author":"V De Pasquale","year":"2018","unstructured":"De Pasquale V, Pezone A, Sarogni P, Tramontano A, Schiattarella GG, Avvedimento VE, et al. EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB. Cell Death Dis. 2018;9:40.","journal-title":"Cell Death Dis"},{"key":"2648_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313\u201326.","journal-title":"Cell"},{"key":"2648_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","volume":"37","author":"LD Archer","year":"2014","unstructured":"Archer LD, Langford-Smith KJ, Bigger BW, Fildes JE. Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity. J. Inherit. Metab. Dis. 2014;37:1\u201312.","journal-title":"J. Inherit. Metab. Dis."},{"key":"2648_CR51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00401-007-0325-3","volume":"115","author":"K Hamano","year":"2008","unstructured":"Hamano K, Hayashi M, Shioda K, Fukatsu R, Mizutani S. Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue. Acta Neuropathol. 2008;115:547\u201359.","journal-title":"Acta Neuropathol"},{"key":"2648_CR52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0387-7604(85)80008-5","volume":"7","author":"K Tamagawa","year":"1985","unstructured":"Tamagawa K, Morimatsu Y, Fujisawa K, Hara A, Taketomi T. Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B. Brain Dev. 1985;7:599\u2013609.","journal-title":"Brain Dev."},{"key":"2648_CR53","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1242\/dmm.025171","volume":"9","author":"S Marc\u00f3","year":"2016","unstructured":"Marc\u00f3 S, Pujol A, Roca C, Motas S, Ribera A, Garcia M, et al. Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC. Dis. Model Mech. 2016;9:999\u20131013.","journal-title":"Dis. Model Mech."},{"key":"2648_CR54","doi-asserted-by":"publisher","first-page":"e2296","DOI":"10.1371\/journal.pone.0002296","volume":"3","author":"J Ausseil","year":"2008","unstructured":"Ausseil J, Desmaris N, Bigou S, Attali R, Corbineau S, Vitry S, et al. Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice. PLoS ONE. 2008;3:e2296.","journal-title":"PLoS ONE"},{"key":"2648_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/jnr.10278","volume":"69","author":"HH Li","year":"2002","unstructured":"Li HH, Zhao H-Z, Neufeld EF, Cai Y, G\u00f3mez-Pinilla F. Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B. J. Neurosci. Res. 2002;69:30\u201338.","journal-title":"J. Neurosci. Res"},{"key":"2648_CR56","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","volume":"24","author":"A Ribera","year":"2015","unstructured":"Ribera A, Haurigot V, Garcia M, Marc\u00f3 S, Motas S, Villacampa P, et al. Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy. Hum. Mol. Genet. 2015;24:2078\u201395.","journal-title":"Hum. Mol. Genet"},{"key":"2648_CR57","doi-asserted-by":"publisher","first-page":"e45992","DOI":"10.1371\/journal.pone.0045992","volume":"7","author":"H Fu","year":"2012","unstructured":"Fu H, Bartz JD, Stephens RL, McCarty DM. Peripheral nervous system neuropathology and progressive sensory impairments in a mouse model of Mucopolysaccharidosis IIIB. PLoS One. 2012;7:e45992.","journal-title":"PLoS One"},{"key":"2648_CR58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jnc.14632","volume":"148","author":"H Parker","year":"2019","unstructured":"Parker H, Bigger BW. The role of innate immunity in mucopolysaccharide diseases. J. Neurochem. 2019;148:639\u201351.","journal-title":"J. Neurochem"},{"key":"2648_CR59","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1172\/JCI58644","volume":"122","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J. Clin. Invest. 2012;122:1164\u201371.","journal-title":"J. Clin. Invest"},{"key":"2648_CR60","doi-asserted-by":"publisher","first-page":"824888","DOI":"10.3389\/fnins.2022.824888","volume":"16","author":"EF Garland","year":"2022","unstructured":"Garland EF, Hartnell IJ, Boche D. Microglia and Astrocyte Function and Communication: What Do We Know in Humans? Front Neurosci. 2022;16:824888.","journal-title":"Front Neurosci."},{"key":"2648_CR61","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cellsig.2011.07.005","volume":"23","author":"LM Pavone","year":"2011","unstructured":"Pavone LM, Cattaneo F, Rea S, De Pasquale V, Spina A, Sauchelli E, et al. Intracellular signalling cascades triggered by the NK1 fragment of hepatocyte growth factor in human prostate epithelial cell line PNT1A. Cell Signal. 2011;23:1961\u201371.","journal-title":"Cell Signal"},{"key":"2648_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00259-020-04842-7","volume":"48","author":"AR Coda","year":"2021","unstructured":"Coda AR, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, et al. In vivo imaging of CNS microglial activation\/macrophage infiltration with combined [18F]DPA-714-PET and SPIOMRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis. Eur. J. Nucl. Med Mol. Imaging. 2021;48:40\u201352.","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"2648_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.298","volume":"6","author":"S Anzilotti","year":"2015","unstructured":"Anzilotti S, Tornincasa M, Gerlini R, Conte A, Brancaccio P, Cuomo O, et al. Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype. Cell Death Dis. 2015;6:e2004.","journal-title":"Cell Death Dis."},{"key":"2648_CR64","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.nbd.2021.105480","volume":"159","author":"S Anzilotti","year":"2021","unstructured":"Anzilotti S, Valsecchi V, Brancaccio P, Guida N, Laudati G, Tedeschi V, et al. Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model. Neurobiol. Dis. 2021;159:105480.","journal-title":"Neurobiol. Dis."},{"key":"2648_CR65","doi-asserted-by":"publisher","first-page":"115503","DOI":"10.1016\/j.biopha.2023.115503","volume":"167","author":"S Anzilotti","year":"2023","unstructured":"Anzilotti S, Valente V, Brancaccio P, Franco C, Casamassa A, Lombardi G, et al. Chronic exposure to l-BMAA cyanotoxin induces cytoplasmic TDP-43 accumulation and glial activation reproducing an amyotrophic lateral sclerosis-like phenotype in mice. Biomed. Pharmacother. 2023;167:115503.","journal-title":"Biomed. Pharmacother"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02648-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:51:49Z","timestamp":1757335909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2648"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02648-w","relation":{},"ISSN":["2058-7716"],"issn-type":[{"type":"electronic","value":"2058-7716"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LMP has licensed compositions comprising hepatocyte growth factor or variants thereof for use in the treatment of mucopolysaccharidoses (granted Italian patent MI2014A001454, Title \u201cCompositions for the therapy of mucopolysaccharidoses\u201d). The authors declare no additional competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the Animal Facility of the Department of Molecular Medicine and Medical Biotechnology at the University of Naples Federico II (Naples, Italy) and authorized by the Italian Ministry of Health (Authorization n\u00b0 854\/2021-PR). All procedures complied with the principles and procedures outlined in the ARRIVE guidelines and EU Directive 2010\/63\/EU for animal experiments. No human subjects, tissues, or clinical data were involved in this study; therefore, informed consent and consent for publication of human images are not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"362"}}